FDA NDC Directory · JSON-LD · Markdown

Caspofungin Acetate

NDC 25021-194 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA207092
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsCASPOFUNGIN ACETATE (5 mg/mL)
Marketing started20230715
Package count1

External sources

Source: openFDA. Public-domain (CC0).